IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice (Q79784864)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Francesco Dieli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Simona Buccheri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Rajko Reljic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Juraj Ivanyi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Mahavir Singh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Alfredo Salerno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

729-737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

IL-4 in tuberculosis: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-alpha and in the regulation of fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

IL-4 is required for defense against mycobacterial infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Alternative activation of macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

The many faces of macrophage activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Mechanisms of phagocytosis in macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

IFN-γ and NO in mycobacterial disease: new jobs for old hands

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Macrophages play a dual role during pulmonary tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Leishmania major infection in mice: a model system for the study of CD4+ T-cell subset differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Th 1 and Th 2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

IL-4 receptor signaling is required for mannose receptor expression by macrophages recruited to granulomata but not resident cells in mice infected with Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Macrophage receptors for Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Differential effects of interleukin-4 and interleukin-10 on nitric oxide production by murine macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Murine macrophages cultured with IL-4 acquire a phenotype similar to that of epithelioid cells from granulomatous inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Mucosal immunotherapy of tuberculosis: is there a value in passive IgA?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

The Fc receptor for IgA (FcalphaRI, CD89)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Immunoglobulin A-mediated protection against Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

BCG vaccination of guinea pigs modulates Mycobacterium tuberculosis-induced CCL5 (RANTES) production in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636764

7 January 2021

Identifiers

DOI

10.1002/EJI.200636764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17304630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference